Madhu Mazumdar - Concepedia

Author

Madhu Mazumdar

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Eric B. Larson, M MAZUMDAR, M Mazumdar, M. MAZUMDAR, M. Mazumdar, Madhu Mazumdar, Mazumdar Madhu, Mazumdar, Madhu, Mohua Mazumdar, Moumita Mazumdar

391

Publications

27.7K

Citations

H-Index

220

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Icahn School of Medicine at Mount Sinai Hospital for Special Surgery Paracelsus Medical University

About

Madhu Mazumdar is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	11	12	464
2	Arts	2	2	27
3	Engineering	2	2	49
4	Education	1	1	19
5	Management	1	1	84

Madhu Mazumdar

189

Publications

25.5K

Citations

H-Index

Page 1

	Year	Citations
An inflammatory cytokine signature predicts COVID-19 severity and survival Diane M. Del Valle, Seunghee Kim‐Schulze, Hsin-Hui Huang, Nature Medicine InflammationCovid-19 PandemicImmunologyInflammatory Cytokine SignatureInflammatory Marker	2020	2.6K
Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell Carcinoma Robert J. Motzer, Madhu Mazumdar, Jennifer Bacik, Journal of Clinical Oncology	1999	1.8K
Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy, Journal of Clinical Oncology	2002	1.5K
International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers GM Mead, SP Stenning, Penny A. Cook, University of Groningen research database (University of Groningen / Centre for Information Technology)	1997	1K
Prognostic Factors for Survival in Previously Treated Patients With Metastatic Renal Cell Carcinoma Robert J. Motzer, Jennifer Bacik, Lawrence H. Schwartz, Journal of Clinical Oncology	2004	800
Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma Abby B. Siegel, E. Cohen, Allyson J. Ocean, Journal of Clinical Oncology	2008	506
Treatment Outcome and Survival Associated With Metastatic Renal Cell Carcinoma of Non–Clear-Cell Histology Robert J. Motzer, Jennifer Bacik, Tania Mariani, Journal of Clinical Oncology	2002	495
Perioperative Comparative Effectiveness of Anesthetic Technique in Orthopedic Patients Stavros G. Memtsoudis, Xuming Sun, Ya-Lin Chiu, Anesthesiology	2013	486
TERATOMA WITH MALIGNANT TRANSFORMATION: DIVERSE MALIGNANT HISTOLOGIES ARISING IN MEN WITH GERM CELL TUMORS Robert J. Motzer, Alison Amsterdam, Víctor G. Prieto, The Journal of Urology	1998	432
Postoperative Nomogram for Disease-Specific Survival After an R0 Resection for Gastric Carcinoma Michael W. Kattan, Martin S. Karpeh, Madhu Mazumdar, Journal of Clinical Oncology	2003	406

Page 1